GlassScriptPhysician profile
Eric M Goldberg
NPI 1083664312
$109,882.65
in general payments reported to CMS, 2019-2025
14 companies · $13K in 2025
The $13K reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,231 · 2020: $34K · 2021: $27K · 2022: $7,897 · 2023: $1,272 · 2024: $20K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Consulting Fee: $7,250 · Food and Beverage: $3,086 · Travel and Lodging: $1,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,400.00 |
| Consulting Fee | $7,250.00 |
| Food and Beverage | $3,086.00 |
| Travel and Lodging | $1,346.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $34,432.34 | 2020-2025 | Exalt Model D, Accolade Sr, Spyglass |
| Covidien LP | $32,090.48 | 2019-2020 | |
| Medtronic, INC. | $27,198.31 | 2021-2022 | |
| Olympus Corporation of The Americas | $7,360.00 | 2019-2020 | |
| Ambu A/S | $6,761.96 | 2022 | |
| Olympus Corporation | $922.50 | 2019 | |
| Ambu INC. | $497.70 | 2021-2023 | |
| Olympus America INC. | $284.82 | 2019-2021 | |
| Abbvie INC. | $151.03 | 2022-2025 | |
| Nestle Healthcare Nutrition INC. | $75.74 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.36 | 2022-2024 | Xifaxan |
| Micro-Tech Endoscopy USA, INC. | $24.24 | 2025 | Eyemax |
| Phathom Pharmaceuticals, INC. | $23.64 | 2024 | Voquezna |
| Conmed Corporation | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.